Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Rossi

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 31, 2022
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequencesFabrizio Tabbò, Lucia Anna Muscarella, Elisa Gobbini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 26, 2018
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based ProposalGiuseppe Pelosi, Mauro Papotti, Luisella Righi, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Plos One|February 13, 2016
Mucorales-Specific T Cells in Patients with Hematologic MalignanciesLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
Lung Cancer (Amsterdam, Netherlands)|January 10, 2025
A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkersErik Thunnissen, Hans Blaauwgeers, Federica Filipello, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2025
Corrigendum to "A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers" [Lung Cancer 199 (2025) 108060]Erik Thunnissen, Hans Blaauwgeers, Federica Filipello, et al.
United European Gastroenterology Journal|July 29, 2025
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)Mohammad Abu Hilal, Bas A Uijterwijk, Daniël H L Lemmers, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|August 31, 2022
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequencesFabrizio Tabbò, Lucia Anna Muscarella, Elisa Gobbini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 26, 2018
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based ProposalGiuseppe Pelosi, Mauro Papotti, Luisella Righi, et al.
Archives of Pathology & Laboratory Medicine|September 12, 2019
Correlation of ROS1 Immunohistochemistry With <i>ROS1</i> Fusion Status Determined by Fluorescence In Situ HybridizationRichard S P Huang, Derek Smith, Catherine H Le, et al.
Plos One|February 13, 2016
Mucorales-Specific T Cells in Patients with Hematologic MalignanciesLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Plos One|September 12, 2013
Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance statusFrancesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
Lung Cancer (Amsterdam, Netherlands)|January 10, 2025
A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkersErik Thunnissen, Hans Blaauwgeers, Federica Filipello, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2025
Corrigendum to "A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers" [Lung Cancer 199 (2025) 108060]Erik Thunnissen, Hans Blaauwgeers, Federica Filipello, et al.
United European Gastroenterology Journal|July 29, 2025
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)Mohammad Abu Hilal, Bas A Uijterwijk, Daniël H L Lemmers, et al.
Pageof 35